These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29377153)

  • 1. Clinical trials for myasthenia gravis: a historical perspective.
    Kaminski HJ; Alnosair E; Algahtani RM
    Ann N Y Acad Sci; 2018 Feb; 1413(1):5-10. PubMed ID: 29377153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The muddle of mycophenolate mofetil in myasthenia.
    Benatar M; Rowland LP
    Neurology; 2008 Aug; 71(6):390-1. PubMed ID: 18678821
    [No Abstract]   [Full Text] [Related]  

  • 3. Tacrolimus Improves Symptoms of Children With Myasthenia Gravis Refractory to Prednisone.
    Liu C; Gui M; Cao Y; Lin J; Li Y; Ji S; Bu B
    Pediatr Neurol; 2017 Dec; 77():42-47. PubMed ID: 29074055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of studying history: lessons learnt from a trial of tacrolimus in myasthenia gravis.
    Benatar M; Sanders D
    J Neurol Neurosurg Psychiatry; 2011 Sep; 82(9):945. PubMed ID: 21821871
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tacrolimus (FK506) in the treatment of prednisone-resistant myasthenia gravis. Preliminary results of 20 cases].
    Ponseti JM; Fort JM; Espin E; Armengol M
    Med Clin (Barc); 2002 Feb; 118(3):117. PubMed ID: 11825555
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy and safety of tacrolimus in Osserman grade III and Osserman grade IV Myasthenia Gravis.
    Zhao LN; Liang Y; Fang XJ; Liu XM; Jiang QL; Wang SS; She SF; Cao M
    Clin Neurol Neurosurg; 2018 Oct; 173():70-76. PubMed ID: 30092406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability.
    Meriggioli MN; Ciafaloni E; Al-Hayk KA; Rowin J; Tucker-Lipscomb B; Massey JM; Sanders DB
    Neurology; 2003 Nov; 61(10):1438-40. PubMed ID: 14638974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis.
    Muscle Study Group
    Neurology; 2008 Aug; 71(6):394-9. PubMed ID: 18434639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical treatment options for ocular myasthenia gravis.
    Antonio-Santos AA; Eggenberger ER
    Curr Opin Ophthalmol; 2008 Nov; 19(6):468-78. PubMed ID: 18854691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of tacrolimus for myasthenia gravis: a systematic review and meta-analysis.
    Wang L; Zhang S; Xi J; Li W; Zhou L; Lu J; Lu J; Zhang T; Zhao C
    J Neurol; 2017 Nov; 264(11):2191-2200. PubMed ID: 28921038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic and Immunoregulatory Effects of Tacrolimus in Patients with Refractory Generalized Myasthenia Gravis.
    Wu H; Wang Z; Xi J; Liu J; Yan C; Song J; Wang L; Jing S; Wang Y; Zhao C
    Eur Neurol; 2020; 83(5):500-507. PubMed ID: 32932253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive agents for myasthenia gravis.
    Hart IK; Sathasivam S; Sharshar T
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005224. PubMed ID: 17943844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of a patient with severe refractory myasthenia gravis using mycophenolate mofetil.
    Hauser RA; Malek AR; Rosen R
    Neurology; 1998 Sep; 51(3):912-3. PubMed ID: 9748061
    [No Abstract]   [Full Text] [Related]  

  • 14. Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States.
    Burns TM; Sanders DB; Kaminski HJ; Wolfe GI; Narayanaswami P; Venitz J
    Muscle Nerve; 2015 May; 51(5):635-7. PubMed ID: 25704880
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness and safety of tacrolimus therapy for myasthenia gravis: A single arm meta-analysis.
    Wang L; Xi J; Zhang S; Wu H; Zhou L; Lu J; Zhang T; Zhao C
    J Clin Neurosci; 2019 May; 63():160-167. PubMed ID: 30827886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis.
    Sanders DB; Hart IK; Mantegazza R; Shukla SS; Siddiqi ZA; De Baets MH; Melms A; Nicolle MW; Solomons N; Richman DP
    Neurology; 2008 Aug; 71(6):400-6. PubMed ID: 18434638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic efficacy and safety of tacrolimus for intractable myasthenia gravis: a report of 36 patients].
    Feng HY; Liu WB; Qiu L; Huang X; Huang RX
    Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(45):3190-2. PubMed ID: 22333101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil: a new immunosuppressive approach. Successful treatment in a case of myasthenia gravis associated with incomplete lupus erythematosus syndrome and hepatitis C virus infection.
    Caponnetto C; Rossi E; Primavera A
    Eur Neurol; 2001; 46(1):53-4. PubMed ID: 11455187
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis.
    Ponseti JM; Gamez J; Vilallonga R; Ruiz C; Azem J; López-Cano M; Armengol M
    Eur J Cardiothorac Surg; 2008 Nov; 34(5):1062-7. PubMed ID: 18760934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil and tacrolimus: new therapeutic options in neuroimmunological diseases.
    Schneider-Gold C; Hartung HP; Gold R
    Muscle Nerve; 2006 Sep; 34(3):284-91. PubMed ID: 16583368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.